HuagongsheHuagongshe Chemistry Print Report · For research reference only
[3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]acetic acid → 2-[3-(4-Chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-(2-chlorophenyl)-3-hydroxypropyl]acetamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | [3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]acetic acid | HCID 42632357 | — |
| Reactant | N-[1-(2-Chlorophenyl)-3-hydroxypropyl]-2-{3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}acetamide | HCID 59536759 | — |
| Product | 2-[3-(4-Chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-(2-chlorophenyl)-3-hydroxypropyl]acetamide | HCID 59536773 | — |
Reaction Steps
In the same way as for the compound from Example 82, 30 mg (0.10 mmol) of [3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]acetic acid (for preparation see WO 2007/134862, Example 88A) were reacted. This gave 14 mg (30% of theory) of the target compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08202895B2 |
| Source dataset | uspto-grants-2012_06 |
| ORD ID | ord-26f25701642940d88621484437bee8b2 |
| Source note | uspto-grants-2012_06 |